THE ROLE OF SUBGROUPS IN CLINICAL TRIALS Ralph B. D’Agostino, Sr., PhD Boston University September 13, 2005.

Slides:



Advertisements
Similar presentations
The Application of Propensity Score Analysis to Non-randomized Medical Device Clinical Studies: A Regulatory Perspective Lilly Yue, Ph.D.* CDRH, FDA,
Advertisements

C82MST Statistical Methods 2 - Lecture 5 1 Overview of Lecture Testing the Null Hypothesis Statistical Power On What Does Power Depend? Measures of Effect.
Study Size Planning for Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ)
Subgroup Report 7/28/06. Our Aims Purpose of future work: write (at least) one paper describing the landscape of appropriate analytic options. Purpose.
Statistical Analysis and Data Interpretation What is significant for the athlete, the statistician and team doctor? important Will Hopkins
LSU-HSC School of Public Health Biostatistics 1 Statistical Core Didactic Introduction to Biostatistics Donald E. Mercante, PhD.
ODAC May 3, Subgroup Analyses in Clinical Trials Stephen L George, PhD Department of Biostatistics and Bioinformatics Duke University Medical Center.
Controlling the Experimentwise Type I Error Rate When Survival Analyses Are Planned for Subsets of the Sample. Greg Yothers, MA National Surgical Adjuvant.
Biostatistics Case Studies 2006 Peter D. Christenson Biostatistician Session 5: Reporting Subgroup Results.
New or existing slides are easily formatted using built-in layouts that can be applied via the Home tab EMA DRAFT GUIDELINE ON SUBGROUPS DISCUSSION April.
Estimation and Reporting of Heterogeneity of Treatment Effects in Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare.
Research Methods in MIS
Chapter 11: Sequential Clinical Trials Descriptive Exploratory Experimental Describe Find Cause Populations Relationships and Effect Sequential Clinical.
Chapter 11 Survival Analysis Part 2. 2 Survival Analysis and Regression Combine lots of information Combine lots of information Look at several variables.
Lecture 9: One Way ANOVA Between Subjects
Finals Schedule n Section 1: 9:00 AM Monday, May 15.
PY 427 Statistics 1Fall 2006 Kin Ching Kong, Ph.D Lecture 6 Chicago School of Professional Psychology.
Sample Size Determination
Sample Size Determination Ziad Taib March 7, 2014.
OVBIAGELE B, DIENER H-C, YUSUF S, ET AL., PROFESS INVESTIGATORS. LEVEL OF SYSTOLIC BLOOD PRESSURE WITHIN THE NORMAL RANGE AND RISK OF RECURRENT STROKE.
Statistical hypothesis testing – Inferential statistics I.
Are the results valid? Was the validity of the included studies appraised?
Inferential Statistics & Test of Significance
Ch 10 Comparing Two Proportions Target Goal: I can determine the significance of a two sample proportion. 10.1b h.w: pg 623: 15, 17, 21, 23.
Biostatistics Case Studies Peter D. Christenson Biostatistician Session 5: Analysis Issues in Large Observational Studies.
T tests comparing two means t tests comparing two means.
Understanding the Variability of Your Data: Dependent Variable Two "Sources" of Variability in DV (Response Variable) –Independent (Predictor/Explanatory)
The Argument for Using Statistics Weighing the Evidence Statistical Inference: An Overview Applying Statistical Inference: An Example Going Beyond Testing.
A statistical method for testing whether two or more dependent variable means are equal (i.e., the probability that any differences in means across several.
Regression Part II One-factor ANOVA Another dummy variable coding scheme Contrasts Multiple comparisons Interactions.
Systematic Review Module 7: Rating the Quality of Individual Studies Meera Viswanathan, PhD RTI-UNC EPC.
Consumer behavior studies1 CONSUMER BEHAVIOR STUDIES STATISTICAL ISSUES Ralph B. D’Agostino, Sr. Boston University Harvard Clinical Research Institute.
1 Statistical Review Dr. Shan Sun-Mitchell. 2 ENT Primary endpoint: Time to treatment failure by day 50 Placebo BDP Patients randomized Number.
Understanding Research Design Can have confusing terms Research Methodology The entire process from question to analysis Research Design Clearly defined.
1 Lecture note 4 Hypothesis Testing Significant Difference ©
Inference and Inferential Statistics Methods of Educational Research EDU 660.
Tony Panzarella Princess Margaret Hospital / University of Toronto.
AIRE: Acute Infarction Ramipril Efficacy study Purpose To determine whether the ACE inhibitor ramipril reduces mortality in patients with evidence of heart.
April 4 Logistic Regression –Lee Chapter 9 –Cody and Smith 9:F.
1 THE ROLE OF COVARIATES IN CLINICAL TRIALS ANALYSES Ralph B. D’Agostino, Sr., PhD Boston University FDA ODAC March 13, 2006.
Chapter 9 Three Tests of Significance Winston Jackson and Norine Verberg Methods: Doing Social Research, 4e.
Educational Research Chapter 13 Inferential Statistics Gay, Mills, and Airasian 10 th Edition.
One-Way Analysis of Covariance (ANCOVA)
©2010 John Wiley and Sons Chapter 2 Research Methods in Human-Computer Interaction Chapter 2- Experimental Research.
Mixed ANOVA Models combining between and within. Mixed ANOVA models We have examined One-way and Factorial designs that use: We have examined One-way.
CAT 5: How to Read an Article about a Systematic Review Maribeth Chitkara, MD Rachel Boykan, MD.
Tuesday, April 8 n Inferential statistics – Part 2 n Hypothesis testing n Statistical significance n continued….
IMPORTANCE OF STATISTICS MR.CHITHRAVEL.V ASST.PROFESSOR ACN.
Statistical Review of P Acorn’s CorCap Cardiac Support Device
Social Science Research Design and Statistics, 2/e Alfred P. Rovai, Jason D. Baker, and Michael K. Ponton Between Subjects Analysis of Variance PowerPoint.
1 Definitions In statistics, a hypothesis is a claim or statement about a property of a population. A hypothesis test is a standard procedure for testing.
Course: Research in Biomedicine and Health III Seminar 5: Critical assessment of evidence.
European Obesity Academy Assmannshausen 2016 Statistics; power calculation and randomization Johan Bring Statisticon AB.
Critical Appraisal Course for Emergency Medicine Trainees Module 2 Statistics.
Logic of Hypothesis Testing
BIOST 513 Discussion Section - Week 10
These slides highlight a presentation at the Late Breaking Trial Session of the American College of Cardiology 52nd Annual Scientific Sessions in Chicago,
The Importance of Adequately Powered Studies
CLINICAL PROTOCOL DEVELOPMENT
Hypothesis Testing I The One-sample Case
Statistical Core Didactic
Research Design and Analysis
Chapter 8: Inference for Proportions
Crucial Statistical Caveats for Percutaneous Valve Trials
I. Statistical Tests: Why do we use them? What do they involve?
Inferential Statistics & Test of Significance
Helen Barraclough, MSc, Ramaswamy Govindan, MD 
Exercise 1 Use Transform  Compute variable to calculate weight lost by each person Calculate the overall mean weight lost Calculate the means and standard.
Simvastatin in Patients With Prior Cerebrovascular Disease: HPS
Presentation transcript:

THE ROLE OF SUBGROUPS IN CLINICAL TRIALS Ralph B. D’Agostino, Sr., PhD Boston University September 13, 2005

OUTLINE Clinical trial scenarios for subgroup (subset) analysis Illustrations of possible outcomes –GOOD and PROBLEMATIC PRACTICES Role of formal Interaction Test Statistical properties of analyses Closing Comments

POSSIBLE SCENARIOS FOR SUBSET ANALYSIS Primary Hypothesis is for an overall statistically significant effect (All data combined) If Yes –Subgroups examined for consistency –Special subgroups examined for additional effect –Latter two activities are secondary analyses Primary Hypothesis anticipates subgroup effect –Subgroups examined for equal effect to justify pooling and an overall analysis

Primary Hypothesis is for an overall statistically significant effect Primary hypothesis is that two treatments are significantly different If yes to above, concern then is that this should be consistently seen in all relevant subgroups (THIS IS A SECONDARY ANALYSIS)

OVERALL TEST IS SIGNIFICANT

GOOD: T 1 better than T 2 Events Plots over Study Time TREATMENT 1 TREATMENT 2 - Time from randomization in years

Overall Gender Males females Age < 65 >65 Previous Condition Hazard Ratio yes no 1 better 2 better Note: Many subgroups may not show statistical significance, but do show consistentcy

Overall Gender Males females Age < 65 >65 Years with Condition Hazard Ratio yes no Location X NO YES 1 better 2 better Special subgroup

21

Relative Risk Reduction by Qualifying Condition IS n = 6431 MI n = 6302 PAD n = 6452 Total n = Clopidogrel BetterAspirin Better

OVERALL TEST IS NOT SIGNIFICANT TECHNICALLY YOU CANNOT GO BEYOND THIS WITH ANY STATISTICAL STATEMENTS USEFUL TO LOOK AT SUBSETS AS EXPLORATORY ANALYSIS (NOT EVEN APPROPRIATE TO CALL IT A SECONDARY ANALYSIS)

PROBLEM: T1 not better Events Plots over Study Time TREATMENT 1 TREATMENT 2 - Time from randomization in years

Overall Gender Males females Age < 65 >65 Previous Condition Hazard Ratio yes no 1 better 2 better Note: Only age > 65 is “significant.” Do we believe it?

Overall Gender Males females Age < 65 >65 Years with Condition Hazard Ratio yes no Location X NO YES 1 better 2 better Location is “significant”. Was it pre- specified as primary? No

Primary Hypothesis anticipates possible subgroup effect Subgroups identified by pre-randomization or post-randomization stratification Subgroups tests for equal vs. unequal effect. This is done formally by INTERACTION TEST Procedure If significant interaction, do not pool and test groups If no significant interaction pool May need to add variable in analysis for groups

Primary Hypothesis anticipates subgroup effect (continue) INTERACTION TEST may be avoided and subgroups can be tests separately with control of error rates For example, if there are two groups then each can be tested at level of significance For example, groups can be tested sequentially with error rate control

Location X: YES TREATMENT 1 TREATMENT 2 - Time from randomization in years

Location X: NO TREATMENT 1 TREATMENT 2 - Time from randomization in years

Overall Hazard Ratio Location X NO YES 1 better 2 better Location: Interaction of location is significant Do not pool

Statistical properties of analyses Overall test If Primary hypothesis of overall significance is satisfied Then as secondary analyses we can examine subgroups and control error rates (that is, can control chance of identifying falsely significant subgroups) for specified subgroups If number of subgroups is unspecified, then analysis is exploratory even here

Statistical properties of analyses Overall test (continue) If Primary hypothesis of overall significance is not met (that is, we do not achieve statistical significance), then we cannot control error rate (falsely identifying significant subsets). We have used “alpha” on overall test

Primary hypothesis anticipates subgroup differences Level of significance is chance of rejecting at least one false null hypothesis and it can be controlled. If there are potentially k subgroups this error rate may be as high as k(0.05) if each subgroup is tested at 0.05 level of significance. With k=2, 0.10; k=3, 0.15, k=5, 0.25

Closing Comments Error rates (level of significance) can be controlled even for looking at subgroups if structure of statistical approach is clearly stated. We must not confuse test for subgroups stated in a pre-specified manner from post hoc identification and tests